Evaluation of the Usefulness of Adalimumab in Patients with Psoriatic arthritis

Trial Profile

Evaluation of the Usefulness of Adalimumab in Patients with Psoriatic arthritis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Psoriatic arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2017 Status changed from recruiting to active, no longer recruiting.
    • 19 Feb 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 19 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top